Skip to footer
Tölzer Straße 15 (Grünwald).jpg
Photo: Wikitarisch, CC BY-SA 4.0, via Wikimedia Commons

business

ERShares XOVR ETF Investment in Kalshi Reaches $53.1 Million

ERShares XOVR ETF investment in Kalshi reaches $53.1 million after valuation jump

Updated 1 min read

Published by Agyata NewsroomEditorial policyCorrections

Key points

  • ERShares XOVR ETF investment in Kalshi valued at $53.1 million after new financing round
  • Unrealized gain of $23.1 million represents nearly 77% appreciation on original $30 million stake
  • Fund strategy focuses on early-stage private companies like Kalshi and SpaceX before public listing

Why it matters. This development illustrates how retail investors can access private equity growth opportunities through ETFs that bridge the gap between private and public markets, potentially capturing value before companies go public.

Updated Sources: Pulse 2.0

ERShares reported that its XOVR ETF holding in prediction market firm Kalshi grew to approximately $53.1 million following a recent financing round. This unrealized gain of about $23.1 million reflects a valuation jump from the original $30 million stake to a new company value of roughly $40 billion. The fund's strategy targets private businesses early in their development rather than waiting for public market listings.

Latest updates

ERShares XOVR ETF Investment in Kalshi Reaches $53.1 Million

ERShares, the investment adviser to the ERShares Private-Public Crossover ETF (XOVR), reported that its investment in Kalshi has reached an estimated value of $53.1 million. This increase follows a new financing valuation for the prediction markets company Kalshi. The current value represents an unrealized gain of approximately $23.1 million on the fund's original $30 million investment. This development highlights the growing interest in private-public crossover strategies within the investment sector.

Pulse 2.0

Sources

AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.

Topics